NTRA Natera, Inc.
$412.56
Natera, Inc. (NTRA) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.10 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +28.6% since its last earnings release on August 6, 2026.
Natera Reported In-line with Estimates, Raises Guidance
Thursday, August 6, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:05 PM ET
Earnings Whisper
-
vs ($0.10)
Rev est $702.31M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$337.61
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Natera, Inc.
Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw.
Sector
Healthcare
Industry
Medical Labs & Research
Charts powered in part by Lightweight Charts™ by TradingView.